PROSPERA BIOTECH

Prospera Biotech develops and markets innovative neurodermatology products (a.k.a. Nociceuticals®) directed to improve the quality of life (QoL) of people with sensitive & reactive skin caused by pharma treatments or pathologies. Prospera Biotech innovative solutions protect the peripheral nociceptive nervous system by relieving skin sensory distress such as itching, pain, numbness, and tingling. Currently, Prospera Biotech has 5 Nociceuticals® on the market, an exclusive license for using Calmapsin® to alleviate chemotherapy-induced cutaneous discomfort of cancer patients, an international patent application for hyperhidrosis, and 5 products in development to be marketed in 2025-2026.